News

Industry News

View All » Industry News RSS Feed
Alvogen Recalls Fentanyl Patches Due to Mislabeled Doses

Alvogen Recalls Fentanyl Patches Due to Mislabeled Doses

Alvogen, Inc. is voluntarily recalling two lots of Fentanyl Transdermal System 12 mcg/h transdermal patches. Cartons labeled 12 mcg/h Fentanyl Transdermal System patches contained 50 mcg/h patches. Application of a 50 mcg/h patch instead of a prescribed 12 mcg/h patch could result in serious, life threatening, or fatal respiratory depression.

Read More »
FDA Warns Against Sudden Discontinuation of Opioid Medications

FDA Warns Against Sudden Discontinuation of Opioid Medications

The FDA is reminding healthcare professionals that sudden discontinuation of opioid pain medications for patients who are physically dependent can be harmful, resulting in withdrawal symptoms, uncontrolled pain, psychological distress, patients seeking other drugs, and suicide.

Read More »